Company: BLUWU
Filing Date: 2025-03-31
Form Type: S-1/A
Source: 0001641172-25-001410
Chunk: 19

Company: Blue Water Acquisition Corp. III
Filing Date: 2025-03-31
Form: S-1/A
Chunk 19
---
 investment opportunities in the broader healthcare and life sciences sectors encompassing biotechnology, pharmaceuticals, healthcare services, healthcare technology and medical devices and products. With over two decades of experience, Mr. Hermouet has completed more than two dozens of transactions in the biotech, pharma, medtech, and pharma services sectors in both North America and Western Europe. Working closely with senior management and board members, Mr. Hermouet focuses on growth and related financing. Prior to joining Athyrium, Mr. Hermouet was a senior credit analyst at Tribeca Investments, a Citigroup-backed multi-strategy hedge fund, and a credit analyst at Goldman, Sachs & Co. Mr. Hermouet is a CFA Charterholder. Mr. Hermouet holds a bachelor degree in economics as well as a master degree in finance from University Paris Dauphine.

| 5 |

Past performance of our management team and advisors or their affiliates is not a guarantee either (i) of success with respect to any business combination we may consummate or (ii) that we will be able to identify a suitable candidate for our initial business combination. You should not rely on the historical performance record of our management team and advisors or their affiliates as indicative of our future performance. Our officers and directors may have conflicts of interest with other entities to which they owe fiduciary or contractual obligations with respect to initial business combination opportunities. For a list of our officers and directors and entities for which a conflict of interest may or does exist between such persons and us, as well as the priority and preference that such entity has with respect to performance of obligations and presentation of business opportunities to us, please refer to the table and subsequent explanatory paragraph under “ Management — Conflicts of Interest.”

We believe our management team and advisors have the skills and experience to identify, evaluate and consummate a business combination and is positioned to assist businesses we acquire. However, our management team and advisors’ network and investing and operating experience do not guarantee a successful initial business combination. The members of our management team and advisors are not required to devote any significant amount of time to our business and are concurrently involved with other businesses. There is no guarantee that our current officers and directors will continue in their respective roles, or in any other role, after our initial business combination, and their expertise may only be of benefit to us until our initial business combination is completed.

| 6 |

Acquisition Criteria We have identified the following general criteria and guidelines that we believe are important in evaluating prospective targets. We